Theravance Biopharma
TBPH
#6972
Rank
โ‚น38.16 B
Marketcap
Country
โ‚น771.51
Share price
-0.11%
Change (1 day)
1.72%
Change (1 year)

Market capitalization of Theravance Biopharma (TBPH)

Market cap: โ‚น38.16 Billion

As of April 2025 Theravance Biopharma has a market cap of โ‚น38.16 Billion. This makes Theravance Biopharma the world's 6972th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Theravance Biopharma from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น38.16 B-5.66%
2024โ‚น40.45 B-13.18%
2023โ‚น46.59 B-25.5%
2022โ‚น62.54 B3.19%
2021โ‚น60.61 B-27.49%
2020โ‚น83.60 B-20.58%
2019โ‚น105.26 B5.65%
2018โ‚น99.63 B3.41%
2017โ‚น96.34 B-14.38%
2016โ‚น112.52 B172.01%
2015โ‚น41.36 B35.78%
2014โ‚น30.46 B

End of Day market cap according to different sources

On Apr 2nd, 2025 the market cap of Theravance Biopharma was reported to be:

โ‚น38.16 Billion
by Nasdaq info icon info icon
โ‚น38.16 Billion
by CompaniesMarketCap info icon info icon
โ‚น38.16 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น82.54 B 116.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น757.14 B 1,883.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น254.37 B 566.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น986.63 B 2,485.06%๐Ÿ‡บ๐Ÿ‡ธ USA